Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work

Journal of Dermatology

Volumn 38, Issue 2, 2011, Pages 155-159

  Zhao, Zigang ^a   Li, Ying ^a   Li, Yuanyuan ^a   Zhao, Hua ^a   Li, Hengjin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

hyperostosis; pustulosis; SAPHO; synovitis

Indexed keywords

ACETYLSALICYLIC ACID; AURANOFIN; AZATHIOPRINE; CALCIPOTRIOL; CORTICOSTEROID; DICLOFENAC; ETANERCEPT; ETRETIN; HYDROXYCHLOROQUINE; INFLIXIMAB; ISOTRETINOIN; KETOPROFEN; LEFLUNOMIDE; MEFENAMIC ACID; METHOTREXATE; NABUMETONE; PAMIDRONIC ACID; PENICILLAMINE; PIROXICAM; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; ZOLEDRONIC ACID;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; PATHOGENESIS; PHYSICAL EXAMINATION; PUSTULOSIS PALMOPLANTARIS; SAPHO SYNDROME; SKIN BIOPSY; TREATMENT OUTCOME;

ACQUIRED HYPEROSTOSIS SYNDROME; ADULT; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HAND DERMATOSES; HUMANS; ISOXAZOLES; LEG DERMATOSES; METHOTREXATE; TREATMENT OUTCOME;

EID: 79251540607     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00931.x     Document Type: Article

References (13)

1. Chamot AM, Benhamou CL, Kahn MF, et al. Acne-pustulosis-hyperostosis- osteitis syndrome. Result of a national survey 85 cases. Rev Rhum Mal Osteoartic 1987; 54: 187-196.
2. Grossman ME, Rudin D, Scher R,. SAPHO syndrome: report of three cases and of the literature. Cutis 1999; 64: 253-258.
3. Earwaker JW, Cotten A,. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol 2003; 32: 311.
4. VanDoornum S, Barraclough D, McColl G, et al. SAPHO: rare or just not recognized. Semin Arthritis Rheum 2000; 30: 70-77.
5. Massara A, Cavazzini PL, Trotta F,. In SAPHO syndrome anti-TNF-a therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology 2006; 45: 730-733.
6. Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, et al. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology 2008; 47: 1160-1167.
7. Schuster T, Bielek J, Dietz HG, et al. Chronic recurrent multifocal osteomyelitis (CRMO). Eur J Pediatr Surg 1996; 6: 45-51.
8. Priyadarshani B, Bruce B, Lamk L,. The SAPHO syndrome: a case report of a patient with unusual bone scan findings. Clin Nucl Med 2001; 26: 619-621.
9. Takano Y, Nomura E, Nakayama M, et al. Two cases of SAPHO syndrome accompanied by classic features of Behcets disease and review of the literature. Clin Rheumatol 2008; 27: 133-135.
10. Gupta AK, Skinner AR,. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 2004; 8: 77-89.
11. Iqbal M, Michael SK,. Acne fulminans with synovitis-acne- pustulosishyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermarol 2005; 52: 118-120.
12. Robert I, Matthias L, Costakis G, et al. Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol 1999; 3: 198-208.
13. Malviya A, Kuiper JH, Makwana N, et al. The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study. J Orthop Surg Res 2009; 4: 17.